1. Home
  2. HROW vs DGII Comparison

HROW vs DGII Comparison

Compare HROW & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$41.34

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Digi International Inc.

DGII

Digi International Inc.

HOLD

Current Price

$41.92

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
DGII
Founded
1998
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HROW
DGII
Price
$41.34
$41.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$68.86
$46.80
AVG Volume (30 Days)
716.4K
248.3K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.05
EPS
N/A
1.08
Revenue
$250,042,000.00
$430,221,000.00
Revenue This Year
$43.92
$8.57
Revenue Next Year
$41.22
$3.72
P/E Ratio
N/A
$38.81
Revenue Growth
47.83
1.46
52 Week Low
$20.85
$22.39
52 Week High
$50.72
$44.79

Technical Indicators

Market Signals
Indicator
HROW
DGII
Relative Strength Index (RSI) 58.85 65.73
Support Level $36.95 $36.89
Resistance Level $41.24 $43.58
Average True Range (ATR) 2.64 2.23
MACD 0.52 0.52
Stochastic Oscillator 89.48 69.29

Price Performance

Historical Comparison
HROW
DGII

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.

Share on Social Networks: